about
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways...
Read More
4.30
-0.25
(-5.49%)
517.0K
XNAS Volume
XNAS 03 Jun, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Helus Pharma Inc is scheduled for today, for the purpose of Jefferies Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bearish
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..